HEOR & Market Access Consulting For Pharma & Life Science Companies
Faster Market Access. Stronger Value. Better Patient Reach.
Alkemi helps Pharma, Biotech, and Medtech leaders:
- Prove value with clarity and speed
- Build robust evidence
- Improve patient access to breakthrough medical treatments


90-Day Turnaround

Increase Product Value

Improve Patient Access
.avif)
.avif)
You Have A Clear Vision.
We Help Bring It To Life.
Life sciences leaders know they need to mobilize fast. Every month of delayed coverage can cost upwards of $15 million in lost revenue (a conservative estimate from the Day of Delay White Paper).
Missing the chance to collect payer-relevant evidence, targeting the wrong decision-makers, or reacting too slowly to a shifting landscape are preventable mistakes.
And when the value of your treatment isn’t clearly communicated, friction builds - slowing adoption and leaving patients waiting.
With the right plan, every step forward becomes clear, and clinicians, payers, and patients all see the value of your treatment. Here's how.
Evidence package built on the right data
A value story decision-makers can’t ignore
Launch momentum that carries through adoption
You Deserve Evidence That Makes Your Treatment’s Value Undeniable.
Increase And Protect Value With An Evidence-Backed Market Access Plan
Alkemi implements two systems for the challenges our clients face most often. One prepares your launch so you’re ready before threats appear. The other helps you recover fast when access is under pressure. Both give you the clarity and speed to move forward.

Launch Shield™
A proactive defense system that helps you prepare for launch years in advance. We identify risks, guide evidence planning, and align stakeholders so your launch is protected from the start and positioned for long-term success.
Starting at
$150k

Access Threat Response System™
A proven approach for when your treatment is under immediate pressure. We move quickly to assess the situation, build a compelling evidence case, and equip you with the tools to protect value and maintain patient access.
Starting at
$100k

Turn Evidence Into Access With Clarity… And Speed.
Alkemi helps life sciences leaders move from vision to action. We build clear, evidence-based strategies that defend product value, improve patient access, and keep treatment launches on track.
While most HEOR or market access consulting firms spend 6–12 months developing recommendations, Alkemi delivers impact in 90 days. Our process is engineered for speed to give you the insights, evidence, and strategy you need when timing matters most. Without cutting corners. Ever.
Expand And Improve Access With Alkemi
Beyond just “having data,” HEOR and market access is about using it in the right way, at the right time. That’s where Alkemi makes the difference. Our approach gives you faster answers, stronger evidence and clearer value stories while breaking down the silos that slow teams down.

Trusted Expertise,
Proven Impact
Alkemi has been tested in the toughest HEOR and market access challenges — and delivered. With 50+ treatments launched over the past fifteen years and a combined value of tens of billions in global sales, we’ve built a reputation for speed, clarity, and strategies that hold up under pressure.
We’ve partnered with the world’s leading Pharma, Biotech, and Medtech companies and earned trust through results, not talk. Our frameworks were designed in real-world access emergencies, refined over time, and proven to deliver outcomes in 90 days or less.
Recognized by Inc. 5000 and honored for top presentations at ISPOR, Alkemi is a certified woman-owned business with a global track record of excellence.
Testimonials
"When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'."

"Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again."

"Thanks to the whole team involved in staging this Advisory Council. I was fortunate to be able to attend and here the insights from the council members firsthand. The report provides an excellent summary."

"Really appreciate your support - as you know I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months. Thank you so much - this is an important event for our team, companies and clients - and you really helped make it a success. I heard 3 groups leave with ambitions to up their game - and they’re the 3 that need to do it the most - so the message landed as well."


What You Get With Alkemi
Our HEOR and market access solutions deliver a complete package built to help you bring your treatments to market with speed, clarity, and impact.

Threat & Risk Maps
We chart the full decision network (payers, clinicians, guidelines, systems) and pinpoint exact policy shifts, competitive moves, and evidence gaps that put your access at risk.

Stakeholder Insights
Validate and understand the evidence payers, providers, guidelines, and HTAs need to make wise investment decisions. We provide data-driven insights that make it easy to appeal to decision-makers.

Alignment Kits
Internal silos kill momentum. Our frameworks and decision trees align global, regional, and local teams so your organization can make smarter, faster decisions under pressure.

Compelling Playbooks
We provide a clear list of proof requirements and objections, so you know exactly how to respond to objections the moment they appear. You’ll receive pre-approved arguments, countermeasures, and messaging tested against real-world objections.

Adoption Plans
Getting covered is only half the battle. We provide rollout briefs, pull-through plans, and communication tools that make it easy for prescribers, systems, and payers to say yes, so you can optimize access for patients without delay.
Discover The Best Path Forward With Alkemi
We'll tell you exactly what you need to do next - whether that's working with us or handling it internally.






![[digital project] image of media outreach strategy](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/6925e02707522a73c2401f50_iStock-1511464706.avif)


